Skip to content
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Comuniq.EU

EU reviews J&J COVID-19 vaccine for blood clots, expands AstraZeneca probe

epa09097508 Medical staff member prepares shots of the Janssen (Pharmaceutical Companies of Johnson & Johnson) vaccine against Covid-19 during a vaccination operation organized by St. John's Well Child and Family Center in Los Angeles, California, USA, 25 March 2021. St. John's Well Child and Family Center, the Los Angeles County Federation of Labor and immigrant rights groups organized a press conference prior to the vaccination operation to call for immigrants, including undocumented people, to be prioritized in the COVID-19 vaccine rollout. About 400 immigrant community members will be receiving their COVID-19 vaccines throughout the day at the site. EPA-EFE/ETIENNE LAURENT

April 9 (Reuters) – Europe’s drug regulator said on Friday it had started reviewing reports of a bleeding condition in people who had received AstraZeneca’s COVID-19 vaccine and was also looking into Johnson & Johnson’s shot over blood clots.

Four serious cases of rare blood clots with low platelets, one of which was fatal, have been reported after inoculation with J&J’s vaccine from its Janssen unit, the European Medicines Agency said, adding five cases of capillary leak syndrome in people who received AstraZeneca’s vaccine were reported.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)

Filed under Comuniq.EU

More from Comuniq.EU

More →